Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 3 Overweight 2 Obesity 2 Colorectal Neoplasms 2 Weight Loss 1 Ovarian Neoplasms 1 Motor Activity 1 Metastatic Pancreatic Adenocarcinoma 1 Lung Neoplasms 1 Leukemia 1 Intermittent Fasting 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Feeding Behavior 1 Fasting 1 Depressive Disorder 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 22 fludarabine 20 venetoclax 8 Whole-Body Irradiation 8 Mycophenolic Acid 8 Standard of Care 6 Mesna 6 Melphalan 6 Azacitidine 6 fludarabine phosphate 5 Sirolimus 5 thymoglobulin 4 Thiotepa 4 Tacrolimus 4 Surveys and Questionnaires 4 Specimen Handling 4 Filgrastim 4 Cytarabine 4 entrectinib 3 daratumumab 3 cobimetinib 3 alectinib 3 Vemurafenib 3 Rituximab 3 Practice Guidelines as Topic 3 Palliative Care 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Bortezomib 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hematologic Neoplasms × Counseling × Clear all

NCT05270096 2026-01-09

iLTB

Princess Maxima Center for Pediatric Oncology

Other hematologic neoplasm

Leukemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡